It has been demonstrated that patients predisposed to the development
of varicose veins have an abnormal venous tone, and may have symptoms
in the absence of obvious varicosities. It has been suggested that ven
otonic drugs relieve the symptoms of chronic venous insufficiency by d
ecreasing capillary leakage and improving venous tone. The aim of this
study was to determine the effect of Daflon 500 mg in patients with a
bnormal venous elasticity without varicose veins. Twenty-five healthy
female volunteers aged 18-35 were included in the study. They presente
d with symptomatic varicose veins in one leg and an abnormal elastic m
odulus without varicosities in the opposite leg. Treatment group: 12 p
atients received 2 tablets of Daflon 500 mg (1000 mg/day); control gro
up: 13 patients received no treatment. The elastic modulus K was deter
mined using the air plethysmograph. Simultaneous measurements of calf
volume changes were made in response to different venous pressures pro
duced by a thigh pneumatic cuff. In the control group K (mean +/- sd)
was 10.8 x 10(3) +/- 4.1 x 10(3) N/m(2) at the beginning and 10.2 x 10
(3) +/- 3.1 x 10(3) N/m(2) at the end of the study (P > 0.1). In the t
reatment group the initial K was 10.2 x 10(3) +/- 3.9 x 10(3) N/m(2) a
nd 14.2 x 10(3) +/- 5.1 x 10(3) N/m(2) at the end (P < 0.02). The resu
lts of the Wilcoxon rank sum test indicated that 4 weeks' therapy with
Daflon 500 mg is effective in improving venous tone in patients with
symptoms but without varicose veins.